Showing results (1161-1170 of 9,119) with videos related to
Sort By:
Pageof 912
Cancer Medicine|March 17, 2022
The prognostic value of prognostic nutritional index in advanced cancer receiving PD-1/L1 inhibitors: A meta-analysisPengfei Li, Yutian Lai, Long Tian, et al.Cancer Medicine|March 17, 2022
Transcriptional profiling demonstrates altered characteristics of CD8+ cytotoxic T-cells and regulatory T-cells in TP53-mutated acute myeloid leukemiaMilad Abolhalaj, Viktor Sincic, Henrik Lilljebjörn, et al.Cancer Medicine|March 21, 2022
Effect of systemic therapies or best supportive care after disease progression to both nivolumab and cabozantinib in metastatic renal cell carcinoma: The Meet-Uro 19BEYOND studyGiandomenico Roviello, Elisabetta Gambale, Roberta Giorgione, et al.Cancer Medicine|March 22, 2022
First-line PD-1/PD-L1 inhibitors plus chemotherapy versus bevacizumab plus chemotherapy for advanced non-squamous non-small cell lung cancer: A Bayesian network meta-analysis of randomized controlled trialsJinzhao Zhai, Jiangyue Lu, Zhibo Zhang, et al.Cancer Medicine|March 22, 2022
The cancer survival index-A prognostic score integrating psychosocial and biological factors in patients diagnosed with cancer or haematologic malignanciesAlexander Gaiger, Simone Lubowitzki, Katharina Krammer, et al.Cancer Medicine|April 19, 2022
Longitudinal monitoring by next-generation sequencing of plasma cell-free DNA in ALK rearranged NSCLC patients treated with ALK tyrosine kinase inhibitorsMinsuk Kwon, Bo Mi Ku, Steve Olsen, et al.Cancer Medicine|April 20, 2022
Identification of a combined apoptosis and hypoxia gene signature for predicting prognosis and immune infiltration in breast cancerXueting Ren, Hanxiao Cui, Jianhua Wu, et al.Cancer Medicine|April 15, 2022
Identity of MMP1 and its effects on tumor progression in head and neck squamous cell carcinomaGehou Zhang, Tieqi Li, Guolin Tan, et al.Cancer Medicine|April 18, 2022
Better or worse? The prognostic role of the mesenchymal subtype in patients with high-grade serous ovarian carcinoma: A systematic review and meta-analysisJuan Chen, Xiaoyan Shi, Lan Xiao, et al.Cancer Medicine|April 18, 2022
Impact of pre-existing interstitial lung abnormal shadow on lung injury development and severity in patients of non-small cell lung cancer treated with osimertinibRyota Shibaki, Yuichi Ozawa, Susumu Noguchi, et al.Pageof 912